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Abstract
A parametric framework for the analysis of transcriptome data is demonstrated to yield coincident results when applied to
data acquired using two different microarray platforms. Microarrays are widely employed to acquire transcriptome
information, and several platforms of chips are currently in use. However, discrepancies among studies are frequently
reported, particularly among those performed using different platforms, casting doubt on the reliability of collected data.
The inconsistency among observations can be largely attributed to differences among the analytical frameworks employed
for data analysis. The existing frameworks are based on different philosophies and yield different results, but all involve
normalization against a standard determined from the data to be analyzed. In the present study, a parametric framework
based on a strict model for normalization is applied to data acquired using several slide-glass-type chips and GeneChip. The
model is based on a common statistical characteristic of microarray data, and each set of chip data is normalized on the
basis of a linear relationship with this model. In the proposed framework, the expressional changes observed and genes
selected are coincident between platforms, achieving superior universality of data compared to other frameworks.
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Introduction
The transcriptome, the contents of mRNA, determines the
functions of a cell. Microarrays are currently widely used to
acquire comprehensive transcriptome information, and thus have
greatly facilitated transcriptome research. However, an appropri-
ate intellectual framework for systematizing the data collected
using various microarrays [1] has yet to be developed. An
intellectual framework is a set of basic assumptions or fundamental
principles [2] that structures the evaluation process. Many
measurements in the natural sciences conform to a framework
based on a universal system of rules, such as the International
System of Units. For the many different types of microarray
platforms, however, it is difficult to transform raw data so as to
accord with any one of the existing frameworks, precluding
reliable comparisons among dissimilar data sets. Consequently,
some form of data normalization is required for processing
microarray data in order to allow intercomparison of raw data.
Data normalization is generally performed by finding certain
definable characteristics in the data that with appropriate
calculations could be used to unify dissimilar data sets. The
characteristics to be unified, the standards, and the set of
calculations are prescribed by an intellectual framework, the basis
of which is the data normalization scheme. Many normalization
methods have been proposed for microarray studies, each with a
different set of basic assumptions. The dissimilarity of the
normalization methods and assumptions constituting the intellec-
tual frameworks thus result in discrepancies when comparing
measurements obtained using different frameworks. As there
presently exists no framework that yields consistent results among
different platforms, the reliability of numerous measurements in
the literature may have been compromised, particularly when
comparisons among different platforms have been performed,
which has raised many questions and criticisms [3–7].
Developing a universal framework for microarray analyses has
proved to be more problematic than may have been expected. The
essential character of a transcript is determined by its concentra-
tion, as the transcript acts as a template for the translation process,
and the rate of translation is linear when compared to the
concentration of the template in the cytosol. However, concen-
trations cannot be measured using present microarray systems.
Measurement of transcripts requires that RNA samples be isolated
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difficult to estimate. Consequently, even if the mass of each
transcript in a sample can be determined, the concentrations
cannot be calculated. This practical imprecision is further
complicated by the variety of platforms available for microarray
systems, which differ with respect to the probe sensitivity of the
hybridization systems and the nucleotide sequences employed.
The potential errors and biases will also differ between platforms,
and the level of additive noise and saturation will vary according to
the measurement approach. Such noise and error contribute to
further discrepancies among data sets. To achieve universality of
data and resolve the problems associated with incompatibility, a
unified intellectual framework is therefore required. Without an
adequate framework that is not affected by measurement
sensitivity and background, even the ratios of expression levels
cannot be estimated correctly as these are framework dependent.
However, relatively little attention has been paid to the
development of such a framework in microarray analyses [1].
A universal intellectual framework for microarray data analysis
should have the capacity to compensate for differences in
measurement related to the differences among platforms and/or
wet procedures. A parametric framework is expected to be suitable
for achieving such universality of data by allowing the transcrip-
tome to be described in terms of parsimonious models based on
thermodynamic models for the formation of the transcriptome in a
cell [8] and the detection of RNA by hybridization [1]. In such a
framework, data could be normalized with respect to a statistical
characteristic common to all measurements. The lognormal
pattern of the data distribution [9] has been proposed as a
promising basis for a parametric framework. By this approach, an
appropriate background specific to each hybridization is first
subtracted from the data. The logarithms of the background-
corrected data are then modified by subtracting a parameter
representing the center of the distribution (m), and then by dividing
by a parameter representing the width of the distribution (s). The
normalized data sets are then compared to a lognormal
distribution model to verify the suitability of the applied model.
This approach allows the normalized data to be compared with
other normalized data on the basis of linear characteristics.
Measurements can also be made to test the lowest value unaffected
by additive noise and the highest value unaffected by saturation,
since the data diverge from the expected pattern at these limits [9].
The differences among normalized data can then be evaluated
using generalized linear models [1,8,9].
In the present study, the universality of a parametric framework
is tested by comparing data acquired using several different
microarray platforms. While differences in the measurement
positions of each transcript could alter the obtained information,
the overall trend in the information obtained from platforms
should coincide. To test the coincidence, a series of data were
obtained from a rat toxicology project study [10]. Multi-sample
RNA isolated from rat organs were then hybridized to two
platforms: an in-house microarray (ToxArray III), and the
GeneChip microarray in three different laboratories [11,12].
The ToxArray III is a typical microarray on slide glass, consisting
of a single 60 mer probe per gene, and two samples are measured
simultaneously per chip. In contrast, the GeneChip consists of 11
perfect match (PM) and miss match (MM) 25 mer probes per gene,
and a single sample is measured per chip. In this report, the
coincidence of information is checked by examining the measured
logarithmic ratios and gene candidates that may be affected by
Safrol [12] treatment. An additional series of data was obtained
from an inter-platform comparison study [13] in which two pooled
mouse RNA samples were hybridized to various slide-glass and
GeneChip platforms. All data were normalized using a parametric
framework based on a three-parameter lognormal distribution
model [1,9]. In order to evaluate the methodology, GeneChip
data were also normalized using both MAS5 [14] and RMA [15],
slide-glass arrays with a two-color system were normalized by the
LOEWSS method [16], and slide-glass arrays with a single-color
system were normalized by quantile normalization [15]. MAS5 is
the original method described by the manufacturer and involves
classification of genes into ‘‘Present’’, ‘‘Marginal’’, and ‘‘Absent’’
in addition to normalization and summarization of data, and is a
complex framework consisting of many conditional branches.
RMA is a widely used alternative based on the quantile method
[15], in which data distributions of subject data sets are unified by
replacing the entire data set with average data while maintaining
the orders in each data set. LOWESS [16] cancels correlative
trends between signal intensities and logratios by dividing each
pair of data with customized functions. Although these frameworks
are widely used in transcriptome studies, all have a critical
drawback in that the appropriateness of the assumptions
comprising the frameworks have not been verified or are
intrinsically difficult to verify. Most of the assumptions introduce
for the conditional branches in MAS5 lack experimental evidence,
and one of the most basic assumptions, that the amount of
transcript is linear to the PM-MM value, has been proved to be
erroneous [1]. Both quantile normalization and LOWESS
invariably introduce some desired character or bias to the data,
making it difficult to develop appropriate calculations for
verification of the assumptions.
In the test of frameworks, superior coincidence is demonstrated
using the parametric framework. The proposed framework thus
appears to provide a means for the seamless integration of
information obtained in transcriptome studies. The highly reliable
data thus obtained may also provide clues for decoding the
hereditary traits within the genome [8], which may in turn lead to
rapid progress in the life sciences.
Results
Data distribution
The statistical characteristics of the data were determined using
conventional quantile-quantile (QQ) plots (Figure 1 and Support-
ing Information Figure S1). The QQ plot shows the degree of
coincidence between the data distributions of two numeric groups.
The distribution of logarithms of microarray data (y axis) is
compared in Figures 1 and S1 with the theoretical normal
distribution (x axis), that is, sorted normalized data (sorted z scores)
are plotted against the theoretical values. The y=x line thus
represents complete coincidence between the data distribution and
the theoretical prediction, while additive noise in the raw data will
bend the linear relationship in the weakest intensity range.
Although the signal intensity follows the theoretical distribution
pattern over a certain range for both chips, there is a marked
difference in the valid intensity range between the two chips. The
narrower valid range for ToxArray data suggests a higher level of
additive noise. The distribution of ToxArray data has a larger
scale parameter (s) than that of GeneChip data, with median
values of 1.02 and 0.685, respectively. The dynamic range of
signals, estimated from the ratio of the strongest to weakest signal
for 10 000 measurements, is 2610
5 for GeneChip, and 1610
8 for
ToxArray. The higher s value is likely to result in measurements
exceeding the limits of the scanner, which usually covers a range of
10
4–10
5. Additionally, unevenness in hybridization, as observed
from the pseudo images [17], was substantially higher for
ToxArray (see Supporting Information Figure S2).
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platforms
For the genes common to slide-glass-type chips and GeneChip,
the logarithmic ratios determined by different frameworks are
compared in Figure 2. In the parametric framework, the
logarithmic ratios are coincident in the valid signal range
(Figure 2, left). Outside of the valid range, however, data obtained
using slide-glass-type chips become substantially divergent, while
the GeneChip data remain relatively close to the y=x line. This
may indicate the noise reduction effect associated with the
GeneChip due to the averaging of multiple PM cells for each
gene. In contrast, larger differences were observed between the
LOWESS- and RMA-normalized data (Figure 2, center and
right). The coincidence between LOWESS and MAS5 results is
very poor for data labeled ‘‘Absent’’ in MAS5, but improved
coincidence was observed for the ‘‘Present’’ data, although such a
relationship should not always be expected; for example, almost no
coincidence was observed in other cases (see Supporting
Information Figure S3).
Coincidence in selected genes
The lists of genes exhibiting expressional changes larger than
the threshold levels determined by noise level estimations are
compared in Figure 3. The numbers of selected genes correspond
to the estimated magnitude of differences and fluctuations in
measurements. Using the parametric framework, a larger overlap
and smaller disagreement between the lists for each platform are
obtained. This comparison also reveals differences in the detection
power of the chips. For example, 319 genes selected by GeneChip
were out of the detection range of ToxArray. Comparisons
between LOWESS and RMA or MAS5 methods resulted in a
markedly smaller overlap of selected genes (see Supporting
Information Figure S4). Many genes were selected by only one
of the platforms, indicating that the parametric framework does
not account for other substantial differences that exist between
platforms. Such conflicts suggest the inclusion of more false
positives than expected for the test.
Trends in selected gene contents were also observed using the
parametric framework. In estimating the physiological condition of
the sample, the simultaneous selection of a group of genes
indicative of a biological event is a more reliable indicator of that
event than the selection of a single pertinent gene. In the present
case, the parametric framework reveals an increase in genes
related to proteolysis by proteasomes and metabolism of steroids,
and a reduction in genes related to antigen presentation via MHC
class II. These genes constituted large parts of the gene list
Figure 1. QQ plots showing the distribution of normalized data for signals obtained for the same RNA sample. (A) NEDO ToxArray III
spots (without controls), (B) GeneChip PM data from the toxicology study, and (C) MWG chip data from platform comparison studies. Red line
denotes y=x, and arrows denote valid range of data with respect to model fit. (D) Simulated data distribution. Lognormally distributed signals form a
straight line on the QQ plot (black), while those with various levels of normally distributed noise fall in the lowest range (colored dots). Interactive
commands used in the R simulation are provided in Supporting Information S1.
doi:10.1371/journal.pone.0003555.g001
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PLoS ONE | www.plosone.org 3 October 2008 | Volume 3 | Issue 10 | e3555Figure 2. Coincidence in log2 ratio among estimations of expressional differences for slide-glass-type chips and GeneChip. Data
plotting on the y=x line (green) are coincident between platforms. Signals out of the valid range of the parametric and MAS5 framework are plotted
in blue (GeneChip) or orange (slide-glass).
doi:10.1371/journal.pone.0003555.g002
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specific function in the selected gene group results in a bias or
tendency within the group that is different from that of the
population. Such bias can be resolved by applying some of the key
words included in the gene annotations for the chips. Table 1
shows the appearance ratio and p values for genes that include a
key word for steroid metabolism, proteasome, or major histocom-
patible complex. Significant biases were only resolved by the
parametric method. Additionally, out of 100 key words randomly
selected from selected genes, 13 were judged to be significant by
the parametric framework, whereas only 4 and 1 words of this
group of 13 were determined to be significant by the RMA_LO-
WESS and MAS5_LOWESS frameworks, respectively. The
superior sensitivity of the parametric framework for resolving
such bias cannot be achieved simply by increasing the number of
selected genes through adjustment of the threshold.
Figure 3. Summary of selected genes showing coincidence between platforms. Values denote number of genes selected for each of the
array platforms. Signals outside of the valid model range are omitted (parametric and MAS5 framework). Isolated areas represent the genes that
could not be determined in the other platform due to the limitation of signal range.
doi:10.1371/journal.pone.0003555.g003
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The parametric framework appears to provide superior
reproducibility with greater testing power and a lower false-
positive rate compared to existing frameworks. In the present
study, although the purpose and subjects of measurement were
identical, the analytical results were not coincident between
platforms. The degree of coincidence and conflict appears to be
largely dependent on the framework employed for analysis of the
acquired data. Many of the discrepancies in the information
obtained from the two platforms considered here can be attributed
to differences in the fundamental philosophies of the frameworks
that have conventionally been applied to the respective platforms,
and not to inherent differences in the capacities of the chip
platforms. This is evidenced by the greater coincidence achieved
between data acquired using different platforms when analyzed
using the parametric framework.
Each of the frameworks normalizes and compares data using a
set of hypotheses and assumptions that form the fundamental basis
of the framework [1,2]. In the parametric framework, chip data
are normalized using a distribution model as the standard. Here
the term ‘‘parametric’’ means a strict description with the least
number of parameters and the least number of assumptions. On
the other hand, a standard is sought among the data sets in the
other frameworks. For example, the standard in other frameworks
may be determined for a pair of data in LOWESS [16] and shift-
log [18], and from the means of data quantiles in RMA.
Consequently, the normalization of a data set in existing
frameworks is affected by all of the data sets being processed at
the same time. This dependency on other data sets can be
expected to adversely affect the uniformity of the analysis, which
becomes apparent when comparing information among different
studies.
Another fundamental difference is associated with the testability
of the fundamentals of the framework. LOWESS and quantile
methods including RMA inevitably fulfill the assumptions
Figure 4. Functions of cross-selected genes in the toxicology study estimated from gene titles and biological processes of gene
annotations provided by the chip manufacturer.
doi:10.1371/journal.pone.0003555.g004
Table 1. List of ratios and p values of selected genes marked
with a key word.
Increase Parametric RMA_LOWESS MAS_LOWESS
Ratio p Ratio p Ratio p
Cholesterol 4/47 2.7E-05 0/38 1 0/30 1
Steroid 6/47 9.6E-05 2/38 0.1 3/30 0.01
Macropain 9/47 2.1E-12 0/38 1 0/30 1
Proteasome 9/47 4.5E-12 0/38 1 0/30 1
Decrease Ratio p Ratio p Ratio p
Antigen 7/62 8.9E-08 0/25 1 0/17 1
Extracellular space 7/62 8.6E-05 1/25 0.2 2/17 0.03
Histocompatibility 2/62 8.4E-04 0/25 1 0/17 1
MHC & RT1 5/62 1.7E-06 0/25 1 0/17 1
doi:10.1371/journal.pone.0003555.t001
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form of stable logarithmic ratios (LOWESS) or identical data
distributions (quantile method). MAS5 contains numerous condi-
tional judgments that are not based on factual knowledge. The
premises of these frameworks therefore preclude effective
evaluation of the model assumptions. The parametric framework,
on the other hand, employs a strict model and normalization
cannot be completed without coincidence between the model and
chip data. Any test of validity therefore relates to the reliability of
the obtained information.
The normalization process, which tests data distribution against
a model (Figure 1), is useful for identifying the likely range of data.
As with other measurement systems, microarrays inevitably
contain noise. With repeated measurements such as those shown
in Figure 3, the noise level can be reduced by taking the means of
repeats. However, the noise contained in each measurement may
still affect analyses, particularly when small numbers of repeats are
available. Even in such cases, the parametric framework allows the
data range that is likely to be affected by additive noise and
saturation to be clearly defined (Figure 1). The usefulness of this
method for data classification is clearly shown in Figure 2, and is
expected to increase the reliability of analyses by reducing the
false-positive rate.
The parsimonious character of the proposed parametric
framework assists in maintaining objectivity in analyses. As the
summarization of data with perfect objectivity in order to obtain
abstract representations of measurements such as shown in
Figure 4 is quite difficult, analysts tend to depend on personal
criteria to judge the importance of each piece of information.
However, by the proposed approach, the false-positives appearing
in the abstracted data can be controlled, allowing significant
increases in cell function apparent in the microarray data to be
tested by reference to the binominal distribution model (Table 1).
If the function is significant, many of the related key words will
become significant by this test. On the other hand, if only a limited
part of the key words tested show significance, the estimation of
cell function should be reconsidered by altering the category of the
function or by focusing on the speciality of the function. It should
be noted that this test can cause multiple comparison problems, as
false-positives will occur in accordance to the threshold value.
Furthermore, some positive key words will not directly represent
the probability of functional change, since many key words are not
independently used in annotations, and may be correlated.
However, such factors will not disturb the testing of each word
or phrase. The present tests clearly show that the proposed
parametric framework has superior sensitivity compared to the
other frameworks evaluated in this study, corresponding to lower
levels of false selection of genes.
The proposed parametric framework thus achieves superior
universality of data and allows for the evaluation of data reliability,
thereby providing a means of integrating knowledge obtained from
many different laboratories and chip platforms.
Materials and Methods
Test animals and microarrays used in the toxicology
study
Male Fischer 344 rats (SPF, 5 weeks of age) were administered
with 300 mg/kg/day of Safrol for up to 28 days at the Mitsubishi
Chemical Safety Institute [11,12]. RNA samples were isolated from
the liver of each test animal. Identical RNA samples were
investigated using GeneChip (Rat Genome 230 2.0 array;
Affymetrix) and a NEDO-ToxArray III ink-jet printed chip (6709
genes [10]). These microarrays share an overlap of 4433 genes.
Data obtained from the Gene Expression Omnibus
Data sets employed in a platform comparison study [13] were
obtained from the Gene Expression Omnibus [19]. In the
comparison study, two batches of RNA (mouse cortex samples
and retina samples) were hybridized to 9 platforms: ABI,
Amersham, and Mergen (single-color slides); Agilent, Cepko,
MGH, MWG, and Operon Compugen (two-color slides); and
Affymetrix (GeneChip). The present parametric normalization
scheme was applied to the raw signal intensity data for the slide
glass-type chips and the file data (CEL) for GeneChip assays.
Amersham data was not tested due to the non-availability of raw
data. Mergen and Cepko data were not analyzed due to the lack of
information to find correspondences to the other platforms.
Normalization
Parametric normalization was performed using SuperNORM
(Skylight Biotech, Akita). Other normalizations were performed
using R version 2.4 [20] with the implemented affy library [21] as
follows. The scanner-estimated background was subtracted from
the Cy3 and Cy5 data for each ToxArray chip and the printed
chips in the platform comparison study, and the logarithmic ratios
were stabilized using the LOWESS function [16] in R. The
GeneChip data were normalized and summarized using the
MAS5 function or the RMA [15] function of affy [21]. The data
obtained using Agilent chips were processed by parametric
scanning [17] in order to eliminate data affected by hybridization
unevenness. This step could not be performed for the other chips
due to the lack of necessary information, such as the position of
each spot on the chip. For the remaining data sets from the
platform comparison study, donated normalized values were used.
Estimation of differences in expression levels
The expressional difference for each gene (Eg) between samples
T and C are determined from the means of measurements using
the logarithmic forms of the normalized data for the each chip, as
follows.
Eg~
P
Tg,j
ng,T
{
P
Cg,j
ng,C
Here, ng,T and ng,C are the numbers of available data for samples T
and C, and i denotes the ith chip. Four samples (n=4) were
assigned for treatment and control in the toxicology study, and
n=5 samples were taken for pooled cortex and retina assay in the
platform comparison data. The logratio values are estimated by
unifying the bases of the logarithms to base 2. The parametric
framework data were further adjusted with respect to Eg by
multiplication by the mean s values of measurements [9]. The
logratio values are compared between array platforms in Figure 2.
Comparisons of selected genes
Gene selection was performed for the toxicology and platform
comparison projects using different criteria, although both criteria
are based on the expressional differences and noise levels in
measurements. The differences among frameworks are illustrated
by comparing the genes selected by slide-glass-type chips with
those selected by GeneChip assays. The areas in each diagram
denote the proportion of corresponding genes. The criteria
employed for the toxicology study are as follows. The priority of
selection assigned to the sensitivity in detecting expressional
changes, since the magnitude of differences and the number of
affected genes are expected to be limited. To maximize the
sensitivity, the thresholds were set in consideration of the noise
Parametric Microarray Analysis
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standard deviation of the fluctuations in the normalized logarith-
mic data. The standard deviation was estimated using the mean of
sample variances (sg
2), which was measured for each gene as
follows.
s2
g~
P
Tg,i{Tg
   2z
P
Cg,i{Cg
   2
ng,Tzng,C{2
,
where T ¯ and C ¯ represent the mean of data T and C, respectively.
The threshold level (L) was then determined using the expression
L~3|
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ P
s2
g
ngene
,
s
where ngene is the number of genes. Genes with |Eg| values larger
than L were selected. Assuming that the effects of noise on the
logarithmic data are normally distributed, the false-positive rate of
selection is estimated to be 0.27% in the subject genes. In the
parametric framework, only data in the valid range were used for
selection. In the GeneChip data, differences were estimated at
each PM data level. In MAS5, only ‘‘Present’’ data were used.
Genes without at least 3 cells making successful measurements
within the model-associated signal range in both control and
treatment were excluded.
The criteria used for selected data from the platform
comparison studies were as follows. As differences originate from
the differences between the two organs assayed, excessive numbers
of genes would be selected by the previous criterion. Therefore,
selection was performed by applying a more stringent criterion,
where only those genes with differences in expression levels having
a p value of less than 0.01 and a two-fold variation being selected.
In the estimation of p values, a paired t test was applied for the
two-color printed chips (pairs were formed in a chip-wise manner
giving 5 pairs of data per gene), an unpaired t test was applied for
single-color chips (5 data per gene), and a variance analysis was
applied for GeneChip data by gene-wise pairing in accordance
with PM data (20 pairs of PM data, 5 chips per gene). Forming the
pairs in a chip-wise manner has the advantage of reducing the
number of defects due to uneven hybridization (data not shown).
Test of bias in annotation key words among selected
genes
Augmentation of the specific functions of a cell results in an
increase in the transcripts of genes related to those functions. If
‘‘positive genes’’ are sought by microarray assay, many such
stimulated genes will be selected. Consequently, the selected group
of genes will exhibit trends in the functions of genes, resulting in a
bias in the population of chip contents. Such bias can be detected
in the key words appearing in the annotations for selected genes.
For a certain key word, the appearance rate, ratekey, can be
defined as the proportion of genes for which that key word appears
in the annotations. For a randomly selected group of genes from
the population, the number of ‘‘key’’-annotated genes in the group
will follow a binominal distribution. The probability that the
number of key genes is equal or larger than n in m selected genes
can be expressed by a cumulative distribution function, as given by
X m
i~n
P i=m
  
~
X m
i~n
mCi ratekey
   i 1{ratekey
   m{i ðÞ :
When the probability is less than a threshold value, the
appearance rate of ‘‘key’’-annotated genes in the group is deemed
to be significantly high. In the present study, this procedure was
applied to 100 randomly selected words or phrases, and to words
that represent issues apparent in the diagrams shown in Figure 4.
Evidence for all the words included in the latter test are listed in
Table 1. Random words were chosen from the annotations of 921
genes selected in at least one of the methods or platforms. The
threshold of the test was 0.001, corresponding to one false-positive
in every 1000 key words. For example, the word ‘‘steroid’’
appeared in 70 genes in 4433 overlapping contents of ToxArray
and GeneChip, yielding ratiosteroid value of 0.0158. The
probability that 6 or more genes are included in 47 randomly
selected genes is therefore 9.6E-05. This value is far less than the
threshold, suggesting that the proportion of steroid-related genes is
significantly high.
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